NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
06/05/2026
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Tipo de processo
Eventos registrados
Atualização mais recente
Classificação
Tipo de marca
Classes Nice
Data de depósito
Data de registro
Data de expiração
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
Última transação
Escritório responsável
Código da situação
Cadastro oficial
Código do desenho
Tipo de titular
Localização do titular
Examinador
Localização atual
Titulares
Representantes
GABRIELLE S. ROTH SUGHRUE MION, PLLC
Classes Nice
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
[ Diagnostic reagents for medical purposes; Diagnostic chemical reagents for medical purposes; ] Diagnostic chemical preparations for medical purposes, namely, for diagnosing and monitoring gastroenterological diseases, inflammatory bowel syndrome, inflammatory bowel disease, colitis ulcerosa, Morbus Crohn and for monitoring the effects of TNF-blocker on these conditions; [ diagnostic preparations for medical or veterinary purposes; ] diagnostic preparations for medical purposes [ ; diagnostic preparations for pharmaceutical purposes; reagents for in vitro laboratory tests for medical purposes; reagents for in vitro laboratory use for veterinary purposes ]
Classe 9
[ Computer software for creating searchable databases containing information and data; ] computer software in the nature of a mobile application for use with immunochromatographic devices that test for a specific protein or antigen in a sample of body fluid or stool, and for which the software converts the analytical result to information that can be read by patients and physicians, using mobile phones or smart phones, once calibration data is downloaded from a global computer network; production lot encoded immunochromatographic devices that test for the presence of a specific protein or antigen in a sample of body fluid or stool which is converted to an analytical result that can be read by patients and physicians, using mobile phones or smart phones, once calibration data is downloaded from a global computer network; patient encoded immunochromatographic devices that determine the level of an antigen in a test sample, the results of which can be transmitted through use of a mobile app to a medical advisor, physician or doctor using a mobile phone or smart phone; machine readable immunochromatographic devices, namely, handheld immunochromatographic devices which produce test results that use a mobile app to scan and evaluate the results
Classe 42
[ Biological research, clinical and medical research; ] design and programming of computer software in the medical field [ ; services of a chemical and biological laboratory; analysis of human sera for medical research; medical and pharmaceutical research services ]
Histórico de despachos e eventos da marca no USPTO.
56 publicações encontradas
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
06/05/2026
REGISTERED-SEC.71 ACCEPTED
06/05/2026
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04/05/2026
TEAS SECTION 71 RECEIVED
13/01/2026
NEW REPRESENTATIVE AT IB RECEIVED
21/11/2025
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
26/01/2025
INTERNATIONAL REGISTRATION RENEWED
17/10/2024
PARTIAL INVALIDATION PROCESSED BY THE IB
25/09/2023
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
21/08/2023
INVALIDATION PROCESSED
21/08/2023
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
25/07/2023
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
25/11/2022
REGISTERED-SEC.71 ACCEPTED
25/11/2022
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
22/11/2022
TEAS SECTION 71 RECEIVED
08/06/2022
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
26/01/2021
FINAL DECISION TRANSACTION PROCESSED BY IB
15/07/2016
FINAL DISPOSITION NOTICE SENT TO IB
27/04/2016
FINAL DISPOSITION PROCESSED
27/04/2016
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
26/04/2016
NEW REPRESENTATIVE AT IB RECEIVED
04/03/2016
REGISTERED-PRINCIPAL REGISTER
26/01/2016
NOTIFICATION PROCESSED BY IB
20/11/2015
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/11/2015
PUBLISHED FOR OPPOSITION
10/11/2015
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04/11/2015
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
04/11/2015
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
21/10/2015
LAW OFFICE PUBLICATION REVIEW COMPLETED
02/10/2015
APPROVED FOR PUB - PRINCIPAL REGISTER
23/09/2015
EXAMINER'S AMENDMENT ENTERED
14/09/2015
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
14/09/2015
EXAMINERS AMENDMENT E-MAILED
14/09/2015
EXAMINERS AMENDMENT -WRITTEN
14/09/2015
NOTIFICATION OF FINAL REFUSAL EMAILED
09/09/2015
FINAL REFUSAL E-MAILED
09/09/2015
FINAL REFUSAL WRITTEN
09/09/2015
TEAS/EMAIL CORRESPONDENCE ENTERED
17/08/2015
CORRESPONDENCE RECEIVED IN LAW OFFICE
17/08/2015
ASSIGNED TO LIE
07/08/2015
NEW REPRESENTATIVE AT IB RECEIVED
31/07/2015
TEAS RESPONSE TO OFFICE ACTION RECEIVED
27/07/2015
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/04/2015
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/04/2015
REFUSAL PROCESSED BY IB
20/02/2015
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
30/01/2015
REFUSAL PROCESSED BY MPU
30/01/2015
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
30/01/2015
NON-FINAL ACTION WRITTEN
29/01/2015
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
23/01/2015
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
23/01/2015
NON-FINAL ACTION WRITTEN
22/01/2015
ASSIGNED TO EXAMINER
19/01/2015
APPLICATION FILING RECEIPT MAILED
13/01/2015
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/01/2015
SN ASSIGNED FOR SECT 66A APPL FROM IB
02/01/2015
Proteção contínua da sua marca
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.